Patents/Assignees

Aptamir Therapeutics, Inc.

2 patents in portfolio

US12286625utility2025
Inhibition of Mir-22 Mirna by APT-110
0 cites
US11690804utility2023
Targeted Delivery of Therapeutic Agents to Human Adipocytes
0 cites